Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Tildrakizumab (Anti-IL-23a) For research use only.
Not for use in humans.

Tildrakizumab (Anti-IL-23a)

Synonyms: SCH 900222, MK 3222

Tildrakizumab (Anti-IL-23a) is a humanized monoclonal antibody directed against the p19 protein subunit of interleukin-23 (IL-23), with immunomodulating activity. MW:145.5 KD.

Tildrakizumab (Anti-IL-23a)

Purity & Quality Control

Batch: A243701 Purity: 99% Protein concentration: 6.09mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Tildrakizumab (Anti-IL-23a) is a humanized monoclonal antibody directed against the p19 protein subunit of interleukin-23 (IL-23), with immunomodulating activity. MW:145.5 KD.

Product Details

CAS No. 1326244-10-3
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tildrakizumab (Anti-IL-23a) | Tildrakizumab (Anti-IL-23a) supplier | purchase Tildrakizumab (Anti-IL-23a) | Tildrakizumab (Anti-IL-23a) cost | Tildrakizumab (Anti-IL-23a) manufacturer | order Tildrakizumab (Anti-IL-23a) | Tildrakizumab (Anti-IL-23a) distributor